Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             159 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra™): Immunogenicity and safety profile Czajka, Hanna
2009
27 Supplement 3 p. 6504-6511
8 p.
artikel
2 Activation of toll-like receptor signaling pathway for protection against influenza virus infection Wong, J.P.
2009
27 Supplement 3 p. 3481-3483
3 p.
artikel
3 Altered pathogenicity, immunogenicity, tissue tropism and 3′-7kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos Liu, Shengwang
2009
27 Supplement 3 p. 4630-4640
11 p.
artikel
4 Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer Jasani, B.
2009
27 Supplement 3 p. 3401-3404
4 p.
artikel
5 An E7-based therapeutic vaccine protects mice against HPV16 associated cancer Venuti, Aldo
2009
27 Supplement 3 p. 3395-3397
3 p.
artikel
6 An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague Yamanaka, Hitoki
2009
27 Supplement 3 p. 80-87
8 p.
artikel
7 A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines Peruzzi, Daniela
2009
27 Supplement 3 p. 1293-1300
8 p.
artikel
8 Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine Kitchin, Nicholas
2009
27 Supplement 3 p. 5096-5102
7 p.
artikel
9 Antibody quantity versus quality after influenza vaccination Feng, JingQi
2009
27 Supplement 3 p. 6358-6362
5 p.
artikel
10 Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan Iriemenam, Nnaemeka C.
2009
27 Supplement 3 p. 62-71
10 p.
artikel
11 Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus Sirikwin, Siriwan
2009
27 Supplement 3 p. 4350-4354
5 p.
artikel
12 A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials Boge, Thierry
2009
27 Supplement 3 p. 5677-5684
8 p.
artikel
13 A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali Sagara, Issaka
2009
27 Supplement 3 p. 3090-3098
9 p.
artikel
14 A recombinant replication-defective human adenovirus type 3: A vaccine candidate Li, Haitao
2009
27 Supplement 3 p. 116-122
7 p.
artikel
15 Ascaris suum infection negatively affects the response to a Mycoplasma hyopneumoniae vaccination and subsequent challenge infection in pigs Steenhard, Nina R.
2009
27 Supplement 3 p. 5161-5169
9 p.
artikel
16 A single-dose combination therapy that both prevents and treats anthrax infection Klinman, Dennis M.
2009
27 Supplement 3 p. 1811-1815
5 p.
artikel
17 A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic Lau, Yuk-Fai
2009
27 Supplement 3 p. 1354-1364
11 p.
artikel
18 A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics Hu, Shunlin
2009
27 Supplement 3 p. 904-910
7 p.
artikel
19 Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease Frasch, Carl E.
2009
27 Supplement 3 p. B112-B116
nvt p.
artikel
20 Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice Zheng, Nuoyan
2009
27 Supplement 3 p. 5001-5007
7 p.
artikel
21 Booster vaccination of toddlers with reduced antigen content diphtheria–tetanus–acellular pertussis vaccine Nolan, Terry
2009
27 Supplement 3 p. 2410-2413
4 p.
artikel
22 Brucellosis: The case for live, attenuated vaccines Ficht, Thomas A.
2009
27 Supplement 3 p. D40-D43
nvt p.
artikel
23 Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy) Panatto, D.
2009
27 Supplement 3 p. 3450-3453
4 p.
artikel
24 Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain) Martínez, Ana I.
2009
27 Supplement 3 p. 3496-3498
3 p.
artikel
25 Characterisation of influenza A viruses with mutations in segment 5 packaging signals Hutchinson, Edward C.
2009
27 Supplement 3 p. 6270-6275
6 p.
artikel
26 Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3 Piesche, Matthias
2009
27 Supplement 3 p. 4718-4723
6 p.
artikel
27 Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study Schuller, Elisabeth
2009
27 Supplement 3 p. 2188-2193
6 p.
artikel
28 Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination Opriessnig, T.
2009
27 Supplement 3 p. 1002-1007
6 p.
artikel
29 Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge Platt, Ratree
2009
27 Supplement 3 p. 4508-4519
12 p.
artikel
30 Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector Zhang, Qiwei
2009
27 Supplement 3 p. 1145-1153
9 p.
artikel
31 Contribution of IRF-3 mediated IFNβ production to DNA vaccine dependent cellular immune responses Shirota, Hidekazu
2009
27 Supplement 3 p. 2144-2149
6 p.
artikel
32 Control of pertussis—Lessons learnt from a 10-year surveillance programme in Sweden Carlsson, Rose-Marie
2009
27 Supplement 3 p. 5709-5718
10 p.
artikel
33 Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs Jeuland, Marc
2009
27 Supplement 3 p. 3109-3120
12 p.
artikel
34 Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada Poirier, Béatrice
2009
27 Supplement 3 p. 7105-7109
5 p.
artikel
35 Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam Le, Luan T.
2009
27 Supplement 3 p. F130-F138
nvt p.
artikel
36 Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections Kim, Min-Chul
2009
27 Supplement 3 p. 6688-6694
7 p.
artikel
37 Development of measles vaccines in Japan Ueda, Shigeharu
2009
27 Supplement 3 p. 3230-3231
2 p.
artikel
38 Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART Belaunzarán-Zamudio, Pablo F.
2009
27 Supplement 3 p. 7059-7064
6 p.
artikel
39 Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3–14 years during the annual health examination in private paediatric offices Salleras, L.
2009
27 Supplement 3 p. 3454-3458
5 p.
artikel
40 Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment Lederman, Edith
2009
27 Supplement 3 p. 375-377
3 p.
artikel
41 Editorial Board 2009
27 Supplement 3 p. CO2-
1 p.
artikel
42 Editorial Board 2009
27 Supplement 3 p. CO2-
1 p.
artikel
43 Editorial Board 2009
27 Supplement 3 p. CO2-
1 p.
artikel
44 Editorial Board 2009
27 Supplement 3 p. CO2-
1 p.
artikel
45 Effectiveness of Jeryl Lynn-containing vaccine in Spanish children Castilla, Jesús
2009
27 Supplement 3 p. 2089-2093
5 p.
artikel
46 Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines Pathangey, Latha
2009
27 Supplement 3 p. 2707-2711
5 p.
artikel
47 Effects of hydrostatic pressure on the stability and thermostability of poliovirus: A new method for vaccine preservation Ferreira, Evanilce
2009
27 Supplement 3 p. 5332-5337
6 p.
artikel
48 Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation Cui, Weiguo
2009
27 Supplement 3 p. 2177-2187
11 p.
artikel
49 Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence Bonanni, Paolo
2009
27 Supplement 3 p. A46-A53
nvt p.
artikel
50 Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity Martelli, Paolo
2009
27 Supplement 3 p. 3788-3799
12 p.
artikel
51 Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media Palmu, Arto A.
2009
27 Supplement 3 p. 1490-1491
2 p.
artikel
52 Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM) Li, Ruili
2009
27 Supplement 3 p. 2094-2098
5 p.
artikel
53 Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis Dang, Zhisheng
2009
27 Supplement 3 p. 7339-7345
7 p.
artikel
54 Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis Kathaperumal, Kumanan
2009
27 Supplement 3 p. 123-135
13 p.
artikel
55 Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals Rupprecht, Charles E.
2009
27 Supplement 3 p. 7141-7148
8 p.
artikel
56 Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines Yong, Michelle
2009
27 Supplement 3 p. 3313-3318
6 p.
artikel
57 Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant Cardona, P.J.
2009
27 Supplement 3 p. 2499-2505
7 p.
artikel
58 Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children Esposito, Susanna
2009
27 Supplement 3 p. 633-635
3 p.
artikel
59 Field evaluation of a Mycoplasma bovis bacterin in young dairy calves Maunsell, Fiona P.
2009
27 Supplement 3 p. 2781-2788
8 p.
artikel
60 Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats Laurenzana, Elizabeth M.
2009
27 Supplement 3 p. 7011-7020
10 p.
artikel
61 Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine Lin, Cheng-Tao
2009
27 Supplement 3 p. 7352-7358
7 p.
artikel
62 Ginseng stem–leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice Song, Xiaoming
2009
27 Supplement 3 p. 51-55
5 p.
artikel
63 Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines Rodgers, Gail L.
2009
27 Supplement 3 p. 3802-3810
9 p.
artikel
64 Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection Mueller, Ivo
2009
27 Supplement 3 p. 5633-5643
11 p.
artikel
65 Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen Hodge, James W.
2009
27 Supplement 3 p. 4475-4482
8 p.
artikel
66 Health-care provision factors associated with child immunization coverage in a city centre and a rural area in Kabul, Afghanistan Hemat, Shafiqullah
2009
27 Supplement 3 p. 2823-2829
7 p.
artikel
67 Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies? Leonardi, S.
2009
27 Supplement 3 p. 6030-6033
4 p.
artikel
68 Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count Landrum, Michael L.
2009
27 Supplement 3 p. 4731-4738
8 p.
artikel
69 Homologous prime-boost strategy in neonate mice using Neisseria lactamica Ito, André Y.
2009
27 Supplement 3 p. 3422-3428
7 p.
artikel
70 Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV Jones, Bart
2009
27 Supplement 3 p. 1848-1857
10 p.
artikel
71 Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5 Zhou, Mingguang
2009
27 Supplement 3 p. 5271-5277
7 p.
artikel
72 Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination Zinckgraf, John W.
2009
27 Supplement 3 p. 5393-5401
9 p.
artikel
73 IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content Hendrikx, Lotte H.
2009
27 Supplement 3 p. 6530-6536
7 p.
artikel
74 Immunization of young African green monkeys with OprF epitope 8–OprI–type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa Weimer, Eric T.
2009
27 Supplement 3 p. 6762-6769
8 p.
artikel
75 Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial Chiu, Susan S.
2009
27 Supplement 3 p. 4834-4839
6 p.
artikel
76 Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration Künzi, Valérie
2009
27 Supplement 3 p. 3561-3567
7 p.
artikel
77 Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants Almeida, Volia De Carvalho
2009
27 Supplement 3 p. 3856-3861
6 p.
artikel
78 Immunogenicity of zona pellucida glycoprotein-3 and spermatozoa YLP12 peptides presented on Johnson grass mosaic virus-like particles Choudhury, Sangeeta
2009
27 Supplement 3 p. 2948-2953
6 p.
artikel
79 Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years Østergaard, Lars
2009
27 Supplement 3 p. 161-168
8 p.
artikel
80 Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies Le, Thuy T.T.
2009
27 Supplement 3 p. 3053-3062
10 p.
artikel
81 Importance of subunit vaccine antigen of major Fli C antigenic site of Salmonella Enteritidis II: A challenge trial Toyota-Hanatani, Yukiko
2009
27 Supplement 3 p. 1680-1684
5 p.
artikel
82 Incidence of intussusception among children 0–5 years of age in Thailand, 2001–2006 Khumjui, Chowalit
2009
27 Supplement 3 p. F116-F119
nvt p.
artikel
83 Infection with a low virulent Mycoplasma hyopneumoniae isolate does not protect piglets against subsequent infection with a highly virulent M. hyopneumoniae isolate Villarreal, I.
2009
27 Supplement 3 p. 1875-1879
5 p.
artikel
84 International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 Tondella, M.L.
2009
27 Supplement 3 p. 803-814
12 p.
artikel
85 Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study Arnou, Robert
2009
27 Supplement 3 p. 7304-7312
9 p.
artikel
86 Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice Oma, Keita
2009
27 Supplement 3 p. 3181-3188
8 p.
artikel
87 Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits Jansen, Angelique G.S.C.
2009
27 Supplement 3 p. 2394-2401
8 p.
artikel
88 Investigation of serum bactericidal activity in childhood and adolescence 3–6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine Sakou, Irine-Ikbale
2009
27 Supplement 3 p. 4408-4411
4 p.
artikel
89 In vivo anti-melanoma activities of the Melan-A/MART-1101–115 T CD4+ cell peptide Balasse, Emilie
2009
27 Supplement 3 p. 6107-6109
3 p.
artikel
90 Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults de Voer, Richarda M.
2009
27 Supplement 3 p. 6974-6982
9 p.
artikel
91 Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model Faisal, Syed M.
2009
27 Supplement 3 p. 6537-6545
9 p.
artikel
92 Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity Faisal, Syed M.
2009
27 Supplement 3 p. 378-387
10 p.
artikel
93 Local and regional adverse reactions to BCG-SSI® vaccination: A 12-month cohort follow-up study Dommergues, M.A.
2009
27 Supplement 3 p. 6967-6973
7 p.
artikel
94 Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine Rowhani-Rahbar, Ali
2009
27 Supplement 3 p. 5612-5619
8 p.
artikel
95 Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus Sasaki, Takashi
2009
27 Supplement 3 p. 5174-5177
4 p.
artikel
96 Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan Kao, Jung-Ta
2009
27 Supplement 3 p. 1858-1862
5 p.
artikel
97 Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults Plentz, Annelie
2009
27 Supplement 3 p. 853-856
4 p.
artikel
98 Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur® Children Wittermann, Christoph
2009
27 Supplement 3 p. 1585-1588
4 p.
artikel
99 Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge Schell, John
2009
27 Supplement 3 p. 979-986
8 p.
artikel
100 MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials—Scientific, regulatory and public health perspectives Moorthy, Vasee S.
2009
27 Supplement 3 p. 624-628
5 p.
artikel
101 Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase Tsai, Cheguo
2009
27 Supplement 3 p. 6777-6790
14 p.
artikel
102 MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination Vesikari, T.
2009
27 Supplement 3 p. 6291-6295
5 p.
artikel
103 MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database Pellegrini, Michele
2009
27 Supplement 3 p. 6959-6965
7 p.
artikel
104 Modeling vertical transmission of HIV: Imperfect vaccines can be of benefit Sim, Myung Shin K.
2009
27 Supplement 3 p. 7003-7010
8 p.
artikel
105 Modified intra-cerebral challenge assay for acellular pertussis vaccines: Comparisons among whole cell and acellular vaccines Gaines-Das, R.
2009
27 Supplement 3 p. 6824-6832
9 p.
artikel
106 Molecular epidemiology of Japanese encephalitis in East Asia Morita, Kouichi
2009
27 Supplement 3 p. 7131-7132
2 p.
artikel
107 Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity Khan, Sheema
2009
27 Supplement 3 p. 6080-6087
8 p.
artikel
108 Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein Yuan, Xiaohui
2009
27 Supplement 3 p. 5103-5110
8 p.
artikel
109 Monoclonal antibody based ELISA tests to detect antibodies against neuraminidase subtypes 1, 2 and 3 of avian influenza viruses in avian sera Moreno, Ana
2009
27 Supplement 3 p. 4967-4974
8 p.
artikel
110 Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load Hoegh-Petersen, Mette
2009
27 Supplement 3 p. 6723-6730
8 p.
artikel
111 Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity Sun, Hong-Xiang
2009
27 Supplement 3 p. 3984-3991
8 p.
artikel
112 One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model Fort, M.
2009
27 Supplement 3 p. 4031-4037
7 p.
artikel
113 Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation Seo, Sang Hwan
2009
27 Supplement 3 p. 5906-5912
7 p.
artikel
114 Overcoming innate host resistance to vaccination: Employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception Nikolovski, Sonia
2009
27 Supplement 3 p. 5226-5232
7 p.
artikel
115 Pertussis before and after the introduction of acellular pertussis vaccines in Finland Elomaa, Annika
2009
27 Supplement 3 p. 5443-5449
7 p.
artikel
116 Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine López, Anna
2009
27 Supplement 3 p. 6166-6178
13 p.
artikel
117 Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis Keiser, Paul B.
2009
27 Supplement 3 p. 6809-6813
5 p.
artikel
118 Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure O’Brien, Katherine L.
2009
27 Supplement 3 p. 1863-1868
6 p.
artikel
119 Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics Poolman, Jan
2009
27 Supplement 3 p. 3213-3222
10 p.
artikel
120 PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants Ichinohe, Takeshi
2009
27 Supplement 3 p. 6276-6279
4 p.
artikel
121 Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus Biesova, Zuzana
2009
27 Supplement 3 p. 6234-6238
5 p.
artikel
122 Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus Van Reeth, Kristien
2009
27 Supplement 3 p. 6330-6339
10 p.
artikel
123 Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence Hung, Hui-Fang
2009
27 Supplement 3 p. 6770-6776
7 p.
artikel
124 Production of yellow fever virus in microcarrier-based Vero cell cultures Souza, Marta Cristina O.
2009
27 Supplement 3 p. 6420-6423
4 p.
artikel
125 Protective immunization with homologous and heterologous antigens against Helicobacter suis challenge in a mouse model Flahou, Bram
2009
27 Supplement 3 p. 1416-1421
6 p.
artikel
126 Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines Franka, Richard
2009
27 Supplement 3 p. 7149-7155
7 p.
artikel
127 Recombinant glycoprotein based vaccine for Chandipura virus infection Venkateswarlu, C.H.
2009
27 Supplement 3 p. 2845-2850
6 p.
artikel
128 Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma Cantarella, Giuseppina
2009
27 Supplement 3 p. 3385-3390
6 p.
artikel
129 Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines Prymula, Roman
2009
27 Supplement 3 p. 4739-4740
2 p.
artikel
130 Resistance to mycobacterial infection: A pattern of early immune responses leads to a better control of pulmonary infection in C57BL/6 compared with BALB/c mice Arko-Mensah, John
2009
27 Supplement 3 p. 7418-7427
10 p.
artikel
131 Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells Hu, Ningjie
2009
27 Supplement 3 p. 2994-3006
13 p.
artikel
132 Rotavirus surveillance to determine disease burden and epidemiology in Java, Indonesia, August 2001 through April 2004 Wilopo, Siswanto Agus
2009
27 Supplement 3 p. F61-F66
nvt p.
artikel
133 Saccharomyces cerevisiae as a vaccine against coccidioidomycosis Capilla, Javier
2009
27 Supplement 3 p. 3662-3668
7 p.
artikel
134 Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age Halperin, Scott A.
2009
27 Supplement 3 p. 2540-2547
8 p.
artikel
135 Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study Kaltenböck, A.
2009
27 Supplement 3 p. 4483-4489
7 p.
artikel
136 Scheduling of measles vaccination in low-income countries: Projections of a dynamic model Bauch, C.T.
2009
27 Supplement 3 p. 4090-4098
9 p.
artikel
137 Schistosoma mansoni ex vivo lung-stage larvae excretory–secretory antigens as vaccine candidates against schistosomiasis Ridi, Rashika El
2009
27 Supplement 3 p. 666-673
8 p.
artikel
138 Sentinel Pap smears in 261 invasive cervical cancer patients in Italy Igidbashian, Sarah
2009
27 Supplement 3 p. A34-A38
nvt p.
artikel
139 Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients Cruciani, Mario
2009
27 Supplement 3 p. 17-22
6 p.
artikel
140 Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies Pírez, María Catalina
2009
27 Supplement 3 p. 2689-2694
6 p.
artikel
141 Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario Gasparini, R.
2009
27 Supplement 3 p. 3435-3438
4 p.
artikel
142 Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets Forrest, Heather L.
2009
27 Supplement 3 p. 4187-4195
9 p.
artikel
143 SIP 3: Epidemic and pandemic use of antivirals Antivirals: "you're still the one..." 2009
27 Supplement 3 p. 6377-6379
3 p.
artikel
144 The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine Silfverdal, Sven Arne
2009
27 Supplement 3 p. 1601-1608
8 p.
artikel
145 The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe Jit, Mark
2009
27 Supplement 3 p. 6121-6128
8 p.
artikel
146 The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with β-thalassemia Orthopoulos, George V.
2009
27 Supplement 3 p. 350-354
5 p.
artikel
147 The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine Chattopadhyay, Rana
2009
27 Supplement 3 p. 3675-3680
6 p.
artikel
148 The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Maciag, Paulo Cesar
2009
27 Supplement 3 p. 3975-3983
9 p.
artikel
149 The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice Salem, Mohamed L.
2009
27 Supplement 3 p. 549-557
9 p.
artikel
150 TLR expression and NK cell activation after human yellow fever vaccination da Costa Neves, Patrícia Cristina
2009
27 Supplement 3 p. 5543-5549
7 p.
artikel
151 Toll-like receptor 3 is necessary for dsRNA adjuvant effects Salaun, Bruno
2009
27 Supplement 3 p. 1841-1847
7 p.
artikel
152 Transcription of immune genes upon challenge with viral hemorrhagic septicemia virus (VHSV) in DNA vaccinated rainbow trout (Oncorhynchus mykiss) Cuesta, A.
2009
27 Supplement 3 p. 280-289
10 p.
artikel
153 Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity Giezeman, K.M.
2009
27 Supplement 3 p. 2414-2417
4 p.
artikel
154 Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy Durando, Paolo
2009
27 Supplement 3 p. 3459-3462
4 p.
artikel
155 Use of standardized patients to examine physicians’ communication strategies when addressing vaccine refusal: A pilot study Bryant, Kristina A.
2009
27 Supplement 3 p. 3616-3619
4 p.
artikel
156 Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany Poethko-Müller, Christina
2009
27 Supplement 3 p. 2563-2569
7 p.
artikel
157 Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey Duchet-Niedziolka, P.
2009
27 Supplement 3 p. 1523-1529
7 p.
artikel
158 Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis Gaston, J. S. Hill
2009
27 Supplement 3 p. 5432-5434
3 p.
artikel
159 Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen Mealey, Robert H.
2009
27 Supplement 3 p. 2453-2468
16 p.
artikel
                             159 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland